Salvus Wealth Management LLC increased its stake in Oracle Co. (NYSE:ORCL – Free Report) by 21.6% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,896 shares of the enterprise software provider’s stock after purchasing an additional 1,049 shares during the quarter. Salvus Wealth Management LLC’s holdings in Oracle were worth $824,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. McClarren Financial Advisors Inc. raised its position in shares of Oracle by 201.7% in the fourth quarter. McClarren Financial Advisors Inc. now owns 1,599 shares of the enterprise software provider’s stock worth $266,000 after buying an additional 1,069 shares in the last quarter. Cornerstone Advisory LLC increased its stake in Oracle by 34.1% in the 4th quarter. Cornerstone Advisory LLC now owns 12,968 shares of the enterprise software provider’s stock worth $2,258,000 after acquiring an additional 3,299 shares during the last quarter. Peak Retirement Planning Inc. purchased a new stake in shares of Oracle in the 4th quarter valued at about $211,000. AFT Forsyth & Company Inc. boosted its position in shares of Oracle by 32.7% during the 4th quarter. AFT Forsyth & Company Inc. now owns 6,739 shares of the enterprise software provider’s stock valued at $1,123,000 after acquiring an additional 1,659 shares during the last quarter. Finally, Certuity LLC grew its holdings in shares of Oracle by 28.9% during the fourth quarter. Certuity LLC now owns 7,811 shares of the enterprise software provider’s stock worth $1,302,000 after purchasing an additional 1,753 shares in the last quarter. 42.44% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on the stock. Stephens initiated coverage on shares of Oracle in a research note on Wednesday, March 19th. They issued an “equal weight” rating and a $167.00 target price on the stock. JPMorgan Chase & Co. dropped their price objective on shares of Oracle from $140.00 to $135.00 and set a “neutral” rating for the company in a report on Tuesday, March 11th. Piper Sandler reiterated a “neutral” rating and issued a $130.00 target price (down from $190.00) on shares of Oracle in a research report on Wednesday, April 23rd. Guggenheim restated a “buy” rating and set a $220.00 price target on shares of Oracle in a research report on Thursday, April 3rd. Finally, Morgan Stanley decreased their price target on shares of Oracle from $170.00 to $160.00 and set an “equal weight” rating on the stock in a research note on Wednesday, April 16th. Fourteen investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $174.42.
Insider Transactions at Oracle
In other Oracle news, Director Naomi O. Seligman sold 2,000 shares of the stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $145.81, for a total value of $291,620.00. Following the completion of the sale, the director now owns 34,630 shares in the company, valued at approximately $5,049,400.30. This represents a 5.46% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Leon E. Panetta sold 17,500 shares of the business’s stock in a transaction dated Friday, May 2nd. The shares were sold at an average price of $151.24, for a total value of $2,646,700.00. Following the completion of the transaction, the director now owns 58,090 shares in the company, valued at $8,785,531.60. The trade was a 23.15% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 27,366 shares of company stock worth $4,015,723 in the last three months. Corporate insiders own 42.20% of the company’s stock.
Oracle Price Performance
Shares of ORCL opened at $168.17 on Thursday. Oracle Co. has a twelve month low of $118.86 and a twelve month high of $198.31. The company has a market capitalization of $470.36 billion, a P/E ratio of 41.12, a price-to-earnings-growth ratio of 3.46 and a beta of 1.32. The firm has a 50 day moving average of $145.94 and a 200 day moving average of $160.87. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 5.65.
Oracle (NYSE:ORCL – Get Free Report) last issued its quarterly earnings data on Monday, March 10th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts’ consensus estimates of $1.49 by ($0.02). The company had revenue of $14.13 billion for the quarter, compared to the consensus estimate of $14.40 billion. Oracle had a net margin of 21.16% and a return on equity of 133.25%. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the company earned $1.41 EPS. As a group, equities research analysts anticipate that Oracle Co. will post 5 earnings per share for the current fiscal year.
Oracle Increases Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 23rd. Stockholders of record on Thursday, April 10th were given a dividend of $0.50 per share. This is an increase from Oracle’s previous quarterly dividend of $0.40. The ex-dividend date of this dividend was Thursday, April 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.19%. Oracle’s payout ratio is presently 46.95%.
Oracle Company Profile
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Recommended Stories
- Five stocks we like better than Oracle
- Consumer Discretionary Stocks Explained
- Alphabet Stock Analysis: What’s Next—Bull or Bear Market?
- Insider Trading – What You Need to Know
- 3 Utilities Stocks With Big Earnings, Balanced Risk
- What Do S&P 500 Stocks Tell Investors About the Market?
- NVIDIA Regains Top Spot; FOMO Is Why It Will Continue to Rise
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Co. (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.